Published in Arthritis Res Ther on February 03, 2009
A systems biology approach to synovial joint lubrication in health, injury, and disease. Wiley Interdiscip Rev Syst Biol Med (2011) 1.12
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology (2015) 0.89
High density micromass cultures of a human chondrocyte cell line: a reliable assay system to reveal the modulatory functions of pharmacological agents. Biochem Pharmacol (2011) 0.84
PKCε signalling activates ERK1/2, and regulates aggrecan, ADAMTS5, and miR377 gene expression in human nucleus pulposus cells. PLoS One (2013) 0.81
Prostanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro. Acta Pharmacol Sin (2012) 0.81
Rheumatoid factor positivity is associated with increased joint destruction and upregulation of matrix metalloproteinase 9 and cathepsin k gene expression in the peripheral blood in rheumatoid arthritic patients treated with methotrexate. Int J Rheumatol (2013) 0.79
Pentraxin 3: an immuno-regulator in the lungs. Front Immunol (2013) 0.79
Recent advances in neutralizing the IL-6 pathway in arthritis. Open Access Rheumatol (2009) 0.79
Rationale of using different biological therapies in rheumatoid arthritis. Arthritis Res Ther (2010) 0.77
Genomics and proteomics: Applications in autoimmune diseases. Pharmgenomics Pers Med (2009) 0.75
Ozone Therapy in Ethidium Bromide-Induced Demyelination in Rats: Possible Protective Effect. Cell Mol Neurobiol (2015) 0.75
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 52.74
KEGG for linking genomes to life and the environment. Nucleic Acids Res (2007) 49.37
Genesis: cluster analysis of microarray data. Bioinformatics (2002) 10.50
The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med (1995) 5.83
Matrix metalloproteinases: role in arthritis. Front Biosci (2006) 4.52
The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett (1993) 3.99
Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov (2003) 3.51
Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity (2008) 2.81
Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) (2006) 2.44
Glucocorticosteroids in the management of rheumatoid arthritis. Rheumatology (Oxford) (1999) 2.19
Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum (2002) 2.00
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood (2008) 1.91
Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol (2004) 1.65
Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J (2004) 1.62
Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford) (2003) 1.58
CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes. J Biochem (2008) 1.55
The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res (2004) 1.51
Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol (2005) 1.50
Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. Dev Biol (1997) 1.39
Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol (2000) 1.38
Clinical pharmacology and pharmacogenetics of thiopurines. Eur J Clin Pharmacol (2008) 1.32
Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett (2006) 1.30
Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study. Arthritis Res Ther (2008) 1.28
DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. Genes Immun (2004) 1.20
Glucocorticoids in the treatment of early and late RA. Ann Rheum Dis (2003) 1.20
Differential gene expression in synovium of rheumatoid arthritis and osteoarthritis. Mol Cell Biol Res Commun (2000) 1.14
Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant (2006) 1.14
Contemporary concepts of inflammation, damage and repair in rheumatic diseases. Best Pract Res Clin Rheumatol (2006) 1.13
Rheumatoid arthritis: an overview of new and emerging therapies. J Clin Pharmacol (2005) 1.12
High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res Ther (2003) 1.09
Chondrocyte death induced by pathological concentration of chemokine stromal cell-derived factor-1. J Rheumatol (2006) 0.98
Chemokine inhibition in inflammatory arthritis. Best Pract Res Clin Rheumatol (2006) 0.97
Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen (2007) 0.97
Metabolic activation stimulates acid production in synovial fibroblasts. J Rheumatol (2000) 0.96
Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage. Rheumatology (Oxford) (2002) 0.95
New cytokine targets in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol (2006) 0.94
Characterization of SV40T antigen immortalized human synovial fibroblasts: maintained expression patterns of EGR-1, HLA-DR and some surface receptors. Rheumatol Int (1997) 0.93
Perspectives and limitations of gene expression profiling in rheumatology: new molecular strategies. Arthritis Res Ther (2004) 0.90
Rheumatoid arthritis in 2003: where are we now with treatment? Ann Rheum Dis (2003) 0.90
Sex steroid metabolism in the tibial growth plate of the rat. Endocrinology (2002) 0.89
Modulation of cell recruitment by anti-inflammatory agents in antigen-induced arthritis. Ann Rheum Dis (2002) 0.87
Gene expression profiling of human articular cartilage grafts generated by tissue engineering. Biomaterials (2006) 0.86
The burden of rheumatoid arthritis and access to treatment: a medical overview. Eur J Health Econ (2008) 0.85
Aurothiomalate inhibits COX-2 expression in chondrocytes and in human cartilage possibly through its effects on COX-2 mRNA stability. Eur J Pharmacol (2008) 0.82
Impact of NSAID and steroids on cartilage destruction in murine antigen induced arthritis. J Rheumatol Suppl (1991) 0.81
Serum response elements activate and cAMP responsive elements inhibit expression of transcription factor Egr-1 in synovial fibroblasts of rheumatoid arthritis patients. Int Immunol (1999) 0.81
Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment. Rheumatol Int (2006) 0.81
The anti-rheumatic gold salt aurothiomalate suppresses interleukin-1beta-induced hyaluronan accumulation by blocking HAS1 transcription and by acting as a COX-2 transcriptional repressor. J Biol Chem (2006) 0.80
A review of controlled clinical trials examining the effects of antimalarial compounds and gold compounds on radiographic progression in rheumatoid arthritis. J Rheumatol (2000) 0.78
Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials (2005) 2.60
Scaffold-based tissue engineering: rationale for computer-aided design and solid free-form fabrication systems. Trends Biotechnol (2004) 1.93
Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem (2007) 1.86
Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J Immunol (2004) 1.77
Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood (2007) 1.70
Mechanical testing of fixation techniques for scaffold-based tissue-engineered grafts. J Biomed Mater Res B Appl Biomater (2007) 1.61
Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection. J Infect Dis (2003) 1.60
Diagnosis of periprosthetic infection following total hip arthroplasty--evaluation of the diagnostic values of pre- and intraoperative parameters and the associated strategy to preoperatively select patients with a high probability of joint infection. J Orthop Surg Res (2008) 1.60
Cis- and trans-acting gene regulation is associated with osteoarthritis. Am J Hum Genet (2006) 1.55
Periosteal cells in bone tissue engineering. Tissue Eng (2003) 1.54
Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum (2010) 1.53
Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus. Arthritis Rheum (2008) 1.53
Cardiac surgery for carcinoid heart disease in 12 cases. Gen Thorac Cardiovasc Surg (2011) 1.46
Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous polymer-based three-dimensional chondrocyte grafts: 2-year clinical results. Arthritis Res Ther (2007) 1.45
Autoregulation of Th1-mediated inflammation by twist1. J Exp Med (2008) 1.43
BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture. Differentiation (2003) 1.42
Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. Stem Cells (2009) 1.37
Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther (2005) 1.37
Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc Natl Acad Sci U S A (2009) 1.35
Simvastatin attenuates ventilator-induced lung injury in mice. Crit Care (2010) 1.34
Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study. Arthritis Res Ther (2008) 1.28
Modified immunohistological staining allows detection of Ziehl-Neelsen-negative Mycobacterium tuberculosis organisms and their precise localization in human tissue. J Pathol (2005) 1.26
The human nose harbors a niche of olfactory ectomesenchymal stem cells displaying neurogenic and osteogenic properties. Stem Cells Dev (2010) 1.25
Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation. Arthritis Res Ther (2009) 1.21
Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung. Am J Surg Pathol (2009) 1.19
Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells. J Orthop Res (2011) 1.19
A microcarrier-based cultivation system for expansion of primary mesenchymal stem cells. Biotechnol Prog (2007) 1.19
Formation of cartilage repair tissue in articular cartilage defects pretreated with microfracture and covered with cell-free polymer-based implants. J Orthop Res (2009) 1.19
Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilage. Arthritis Res Ther (2011) 1.19
Validity of frozen sections for analysis of periprosthetic loosening membranes. Clin Orthop Relat Res (2009) 1.15
Regeneration of ovine articular cartilage defects by cell-free polymer-based implants. Biomaterials (2007) 1.12
Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis. Ann Rheum Dis (2010) 1.12
Treatment of focal degenerative cartilage defects with polymer-based autologous chondrocyte grafts: four-year clinical results. Arthritis Res Ther (2009) 1.10
Porcine mesenchymal stem cells. Induction of distinct mesenchymal cell lineages. Cell Tissue Res (2002) 1.10
Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking. Biomaterials (2012) 1.08
Quantitative determination of the diagnostic accuracy of the synovitis score and its components. Histopathology (2010) 1.07
Regulatory T cells control the transition from acute into chronic inflammation in glucose-6-phosphate isomerase-induced arthritis. Ann Rheum Dis (2010) 1.06
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure. Eur Heart J (2013) 1.06
Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res Ther (2006) 1.05
Stem cells for regenerative medicine: advances in the engineering of tissues and organs. Naturwissenschaften (2002) 1.04
Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther (2006) 1.04
Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13. Eur J Cell Biol (2008) 1.04
Mesenchymal stem cell-dependent formation of heterotopic tendon-bone insertions (osteotendinous junctions). Stem Cells (2010) 1.03
Human CD4(+) T cells maintain specific functions even under conditions of extremely restricted ATP production. Eur J Immunol (2008) 1.03
Tissue engineering: advances in in vitro cartilage generation. Trends Biotechnol (2002) 1.03
BMP7 promotes adipogenic but not osteo-/chondrogenic differentiation of adult human bone marrow-derived stem cells in high-density micro-mass culture. J Cell Biochem (2007) 1.02
Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7. Int J Biochem Cell Biol (2008) 1.01
Regenerative treatment strategies in spinal surgery. Front Biosci (2008) 1.00
V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis. Arthritis Rheum (2011) 0.98
Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch (2002) 0.98
miR-148a is upregulated by Twist1 and T-bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim. Eur J Immunol (2015) 0.98
Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum (2007) 0.97
Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen (2007) 0.97
Making bone: implant insertion into tissue-engineered bone for maxillary sinus floor augmentation-a preliminary report. J Craniomaxillofac Surg (2003) 0.96
Chondrogenic differentiation capacity of human mesenchymal progenitor cells derived from subchondral cortico-spongious bone. J Orthop Res (2008) 0.96
Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation. BMC Cell Biol (2010) 0.96
In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells (2008) 0.96